The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis

BACKGROUND: Treatment of severe asthma may include high dose systemic-steroid therapy which is associated with substantial additional morbidity. This study estimates the additional healthcare costs associated with steroid-induced morbidity by comparing three patients groups: those with severe asthma...

Descripción completa

Detalles Bibliográficos
Autores principales: Barry, L. E., Sweeney, J., O’Neill, C., Price, D., Heaney, L. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485660/
https://www.ncbi.nlm.nih.gov/pubmed/28651591
http://dx.doi.org/10.1186/s12931-017-0614-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485660/
https://www.ncbi.nlm.nih.gov/pubmed/28651591
http://dx.doi.org/10.1186/s12931-017-0614-x

Ejemplares similares